ArticleLiver cancer2018

A Phase I/Randomized Phase II Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nintedanib versus Sorafenib in Asian Patients with Advanced Hepatocellular Carcinoma.

Chia-Jui Yen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.